ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 249 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $490,500 | -18.8% | 90,000 | 0.0% | 0.12% | -12.9% |
Q2 2023 | $603,900 | -24.1% | 90,000 | 0.0% | 0.13% | -27.5% |
Q1 2023 | $795,150 | +18.6% | 90,000 | 0.0% | 0.18% | +16.7% |
Q4 2022 | $670,365 | +1.6% | 90,000 | 0.0% | 0.16% | +6.8% |
Q3 2022 | $660,000 | -9.3% | 90,000 | 0.0% | 0.15% | -7.0% |
Q2 2022 | $728,000 | -41.7% | 90,000 | 0.0% | 0.16% | -36.2% |
Q1 2022 | $1,249,000 | -50.5% | 90,000 | 0.0% | 0.25% | -46.8% |
Q4 2021 | $2,525,000 | -17.5% | 90,000 | 0.0% | 0.46% | -22.5% |
Q3 2021 | $3,059,000 | -16.9% | 90,000 | 0.0% | 0.60% | -20.4% |
Q2 2021 | $3,682,000 | +1.6% | 90,000 | 0.0% | 0.75% | -2.7% |
Q1 2021 | $3,623,000 | -31.7% | 90,000 | 0.0% | 0.77% | -36.0% |
Q4 2020 | $5,303,000 | +21.2% | 90,000 | 0.0% | 1.20% | +19.6% |
Q3 2020 | $4,377,000 | +0.5% | 90,000 | 0.0% | 1.01% | +21.9% |
Q2 2020 | $4,354,000 | +59.8% | 90,000 | -10.0% | 0.83% | +39.8% |
Q1 2020 | $2,724,000 | – | 100,000 | – | 0.59% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
Triatomic Management LP | 102,889 | $560,745 | 0.39% |